Article Details
Retrieved on: 2021-02-16 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here